1. Lunn J, Mushin W. Mortality associated with anaesthesia. Anaesthesia 1982; 37:856.
2. Marx G, Mateu C, Orkin L. Computer analysis of postanesthetic deaths. Anesthesiol 1973; 39:54-58.
3. Johnston G, Taylor PM, Holmes M, et al. Confidential enquiry of perioperative equine fatalities (CEPEF-1): preliminary results. Equine Vet J 1995; 27:193-200. - PubMed -
4. Steffey EP. Inhalation Anesthetics and Gases In: WW Muir and JA Hubbell, eds. Equine Anesthesia. St. Louis: Mosby, 1991; 352-379. - Available from amazon.com -
5. Steffey EP. Inhalation Anesthetics In: JC Thurmon, WJ Tranquilli and GJ Benson, eds. Lumb & Jones' Veterinary Anesthesia. 3rd ed. Baltimore: Williams and Wilkins, 1996; 297-329. - Available from amazon.com
6. Steffey EP. Inhalation Anesthetics In: H Adams, ed. Veterinary Pharmacology and Therapeutics. 8th ed. Ames: Iowa State University Press, 2001; 184-212. - Available from amazon.com -
7. Wenker O. Review of currently used inhalation anesthetics: Part I. Internet J Anesthesiol 1999; 3.
8. Finn M. Inhalational Anaesthetics: Kerry Brandis, University of Queensland, 2000.
9. Kelly AB, Steffey EP. Inhalation anesthesia: Drugs and techniques. Vet Clin North Am Large Anim Pract 1981; 3:59-71.
10. Fenton P. Volatile anaesthetic agents. Update in Anaesthesia, 2000. - Available from The World Federation of Societies of Anaesthesiologists, 2000. -
11. Eger EI 2nd. New inhaled anesthetics. Anesthesiol 1994; 80:906-922. - PubMed -
12. Eger EI. Uptake and Distribution In: RD Miller, ed. Anesthesia. 5th ed. Philadelphia: Churchill Livingston, 2000; 74-95. - Available from amazon.com -
13. Kharasch E, Powers K, Artru A. Comparison of Amsorb, Sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound a in swine in vivo. Anesthesiol 2002; 96:173-182. - PubMed -
14. Baum J, van Aken H. Calcium hydroxide lime - a new carbon dioxide absorbent: a rationale for judicious use of different absorbents. Eur J Anaesthesiol 2000; 17:597-600.
15. Dodam JR, Branson KR, Gross ME, et al. Inhaled carbon monoxide concentration during halothane or isoflurane anesthesia in horses. Vet Surg 1999; 28:506-512. - PubMed -
16. Kharasch E, Hoffman G, Thorning D, et al. Role of the renal cystein conjugate beta-lyase pathway in inhaled compound A nephrotoxicity in rats. Anesthesiol 1998; 88:1624-1633.
17. Morio M, Fuji K, Satoh N, et al. Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. Anesthesiol 1992; 77:1155-1164. - PubMed -
18. Keller K, Callan C, Prokocimer P, et al. Inhalation toxicology study of a haloalkene degradant of sevoflurane, compound A (PIFE), in sprague-dawley rats. Anesthesiol 1995; 83:1220-1232. - PubMed -
19. Gonsowski C, Laster M, Eger EI 2nd, et al. Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiol 1994; 80:556-565. - PubMed -
20. Mazze R, Friedman M, Delgado-Herrera L, et al. Renal toxicity of compound A plus sevoflurane compared with isoflurane in non-human primates (abstract). Anesthesiol 1998; 89:A490.
21. Steffey EP, Laster M, Ionescu P, et al. Dehydration of Baralyme increases compound A resulting from sevoflurane degradation in a standard anesthetic circuit used to anesthetize swine. Anesth Analg 1997; 85:1382-1386. - PubMed -
22. Di Filippo A, Marini F, Pacenti M, et al. Sevoflurane low-flow anaesthesia: best strategy to reduce Compound A concentration. Acta Anaesthesiol Scand 2002; 46:1017-1020. - PubMed -
23. Murray J, Renfrew C, Bedi A, et al. Amsorb: A new carbon dioxide absorbent for use in anesthetic breathing systems. Anesthesiol 1999; 91:1342-1348. - PubMed -
24. Osawa M, Shinomura T. Compound A concentration is decreased by cooling anaesthetic circuit during low-flow sevoflurane anaesthesia. Can J Anaesth 1998; 45:1215-1218. - PubMed -
25. Ruzicka J, Hidalgo J, Tinker J, et al. Inhibition of volatile sevoflurane degradation product formation in an anesthesia circuit by a reduction in soda lime temperature. Anesthesiol 1994; 81:238-244. - PubMed -
26. Luttropp H, Johansson A. Soda lime temperatures during low-flow sevoflurane anaesthesia and differences in dead-space. Acta Anaesthesiol Scand 2002; 46:500-505. - PubMed -
27. Simon W, Hapfelmaier G, Kochs E, et al. Isoflurane blocks synaptic plasticity in the mouse hippocampus. Anesthesiol 2001; 94:1058-1065. - PubMed -
28. Bonhomme V, Hans P. Mechanisms of unconsciousness during general anaesthesia. Current Anaesth Crit Care 2001; 12:109-113.
29. Eger EI 2nd, Koblin D, Harris R, et al. Hypothesis: inhaled anesthetics produce immobility and amnesia by different mechanisms at different sites. Anesth Analg 1997; 84:915-918.
30. Greenblatt E, Meng X. Divergence of volatile anesthetic effects in inhibitory neurotransmitter receptors. Anesthesiol 2001; 94:1026-1033. - PubMed -
31. Gaumann D, Mustaki J-P, Tassonyi E. MAC-awake of isoflurane, enflurane and halothane evaluated by slow and fast alveolar washout. Br J Anaesth 1992; 68:81-84. - PubMed -
32. Johnson CB, Taylor PM. Comparison of the effects of halothane, isoflurane and methoxyflurane on the electroencephalogram of the horse. Br J Anaesth 1998; 81:748-753. - PubMed -
33. Fang Z, Sonner J, Laster M, et al. Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis. Anesth Analg 1996; 83:1097-1104. - PubMed -
34. Todd M, Weeks J, Warner D. A focal cryogenic brain lesion does not reduce the minimum alveolar concentration for halothane in rats. Anesthesiol 1993; 79:139-143. - PubMed -
35. Pocock G, Richards C. Excitatory and inhibitory synaptic mechanisms in anaesthesia. Br J Anaesth 1993; 71:134-143. - PubMed -
36. Koblin D. Mechanisms of Action In: R. D. Miller, ed. Anesthesia. 5th ed. Philadelphia: Churchill Livingston, 2000; 48-73. - Available from amazon.com -
37. Dzoljic M. On the search for the mechanism of anaesthetic action. Current Anaesth Crit Care 2000; 11:133-136.
38. Overton C. Studien ueber die Narcose, zugleich ein Beitrag zur allgemeinen Pharmakologie. Jena: Gustav Fischer, 1901.
39. Mullins L. Some physical mechanisms in narcosis. Chem Rev 1954; 54:289-323.
40. Miller K, Paton W, Smith R, et al. The pressure reversal of general anesthesia and the critical volume hypothesis. Mol Pharmacol 1973; 9:131-143.
41. Franks N, Lieb W. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367:607-614. - PubMed -
42. Gyulai F, Mintun M, Firestone L. Dose-dependent enhancement of in vivo GABA(A)-benzodiazepine receptor binding by isoflurane. Anesthesiol 2001; 95:585-593. - PubMed -
43. Hapfelmaier G, Schneck H, Kochs E. Sevoflurane potentiates and blocks GABA-induced currents through recombinant alpha1beta2gamma2 GABAA receptors: implications for an enhanced GABAergic transmission. Eur J Anaesthesiol 2001; 18:377-383. - PubMed -
44. Harris R, Mihic S, Dildy-Mayfield J, et al. Actions of anaesthetics an ligand-gated ion channels: role of receptor subunit composition. FASEB J 1995; 9:1454-1462. - PubMed -
45. Kudo M, Aono M, Massey G, et al. Effects of volatile anesthetics on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cultures. Anesthesiol 2001; 95:756-765. - PubMed -
46. Hashimoto T, Maze M, Ohashi Y, et al. Nitrous oxide activates GABAergic neurons in the spinal cord in Fischer rats. Anesthesiol 2001; 95:463-469. - PubMed -
47. Higueras J, Sarria B, Ortiz J, et al. Halothane inhibits endothelium-dependent relaxation elicited by acetylcholine in human isolated pulmonary arteries. Eur J Pharmacol 1997; 326:175-181. - PubMed -
48. Wallin R, Napoli M. Sevoflurane (fluoro-methyl-1,1,1,3,3,3 hexafluoro-2-propyl ether): a new inhalational anesthetic agent. Fed Procs 1971; 30:442.
49. Wallin R, Regan B, Napoli M, et al. Sevoflurane: a new inhalational anesthetic agent. Anesth Analg 1975; 54:758-765. - PubMed -
50. Aida H, Mizuno Y, Hobo S, et al. Determination of the minimal alveolar concentration (MAC) and physical response to sevoflurane inhalation in the horse. J Vet Med Sci 1994; 56:1161-1165. - PubMed -
51. Fang Z, Eger EI 2nd, Laster M, et al. Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme. Anesth Analg 1995; 80:1187-1193. - PubMed -
52. Hikasa Y, Takase K, Ogasawara S. Sevoflurane and oxygen anaesthesia following administration of atropine-xylazine-guaifenesin-thiopental in spontaneously breathing horses. J Vet Med, Series A 1994; 41:700-708. - PubMed -
53. Peduto V, Mezzetti D, Properzi M, et al. Sevoflurane provides better recovery than propofol plus fentanyl in anaesthesia for day-care surgery. Eur J Anaesthesiol 2000; 17:138-143. - PubMed -
54. Ohta M, Oku K, Yamanaka T, et al. Anesthetic management with sevoflurane and oxygen for orthopedic surgeries in racehorses. J Vet Med Sci 2000; 62:1017-1020. - PubMed -
55. Robinson B, Uhrich T, Ebert T. A review of recovery from sevoflurane anaesthesia: Comparisons with isoflurane and propofol including meta-analysis. Acta Anaesthesiol Scand 1999; 43:185-190. - PubMed -
56. Matthews NS, Hartsfield SM, Mercer D, et al. Recovery from sevoflurane anesthesia in horses: comparison to isoflurane and effect of postmedication with xylazine. Vet Surg 1998; 27:480-5. - PubMed -
57. Aida H, Steffey EP, Pascoe JR, et al. Use of sevoflurane for anesthetic management of horses during thoracotomy. Am J Vet Res 2000; 61:1430-1437. - PubMed -
58. Carroll GL, Hooper RN, Rains CB, et al. Maintenance of anaesthesia with sevoflurane and oxygen in mechanically-ventilated horses subjected to exploratory laparotomy treated with intra- and post operative anaesthetic adjuncts. Equine Vet J 1998; 30:402-407. - PubMed -
59. Cravero J, Surgenor S, Whalen K. Emergence agitation in paediatric patients after sevoflurane anaesthesia and no surgery: a comparison with halothane. Paediatr Anaesth 2000; 10:419-425. - PubMed -
60. Lapin S, Auden S, Goldsmith L, et al. Effects of sevoflurane anaesthesia on recovery in children: a comparison with halothane. Paediatr Anaesth 1999; 9:299-304. - PubMed -
61. Beskow A, Westrin P. Sevoflurane causes more postoperative agitation in children than does halothane. Acta Anaesthesiol Scand 1999; 43:536-541. - PubMed -
62. Read M, Read E, Duke T, et al. Comparison of induction and recovery in foals anesthetized with isoflurane or sevoflurane. Annual Meeting of the American College of Veterinary Anesthesiologists 2001; 30.
63. Greene SA, Benson GJ, Tranquilli WJ, et al. Bispectral index in dogs anesthetized with isoflurane: comparison with sevoflurane. Proc Ann Meeting Am Col Vet Anesthesiol 2001; 21.
64. Manohar M. Regional brain blood flow and cerebral cortical O2 consumption during sevoflurane anesthesia in healthy isocapnic swine. Journal of Cardiovascular Physiology 1986; 8:1268-1275. - PubMed -
65. Scheller M, Nikakimura K, Fleischer J. Cerebral effects of sevoflurane in the dog: Comparison with isoflurane and enflurane. Br J Anaesth 1990; 65:388-392. - PubMed -
66. Monkhoff M, Schwarz U, Gerber A, et al. The effects of sevoflurane and halothane anesthesia on cerebral blood flow velocity in children. Anesth Analg 2001; 92:891-896. - PubMed -
67. Schwender D, End H, Daunderer M, et al. [Sevoflurane and the nervous system]. Der Anaesthesist 1998; 47:S37-42. - PubMed -
68. Drummond J, Todd M, Shapiro H. CO2 responsiveness of cerebral circulation during isoflurane anesthesia and N2O sedation in cats. Anesthesiol 1982; 57:A333.
69. Kitaguchi K, Ohsumi H, Kuro M, et al. Effects of sevoflurane on cerebral circulation and metabolism in patients with ischemic cerebrovascular disease. Anesthesiol 1993; 79:704-709. - PubMed -
70. Smith I, Nathanson M, White P. Sevoflurane - a lon-awaited volatile anaesthtic. Br J Anaesth 1996; 76:435-445.
71. Grosenbaugh DA, Muir WW. Cardiorespiratory effects of sevoflurane, isoflurane, and halothane anesthesia in horses. Am J Vet Res 1998; 59:101-106. - PubMed -
72. Steffey EP. Recent Advances in Inhalation Anesthesia. Vet Clin North Am Equine Pract 2002; 1 (April). - PubMed -
73. Mutoh T, Nishimura R, Kim H-Y, et al. Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs. Am J Vet Res 1997; 58:885-890. - PubMed -
74. Hikasa Y, Kawanabe H, Takase K, et al. Comparison of sevoflurane, isoflurane, and halothane anesthesia in spontaneously breathing cats. Vet Surg 1996; 25:234-243. - PubMed -
75. Steffey EP, Woliner MJ, Mama K. Cardiovascular effects of sevoflurane in horses during spontaneous and controlled ventillation (abstr.). J Vet Anaest 1999; 26:49.
76. Read M, Read E, Duke T. Comparison of the Cardiopulmonary Effects of Isoflurane and Sevoflurane in Foals. Annual Meeting of the American College of Veterinary Anesthesiologists 2001; 34.
77. Yamanaka T, Oku K, Koyama H, et al. Time-related changes of the cardiovascular system during maintenance anesthesia with sevoflurane and isoflurane in horses. J Vet Med Sci 2001; 63:527-532. - PubMed -
78. Steffey EP, Kelly AB, Woliner MJ. Time-related responses of spontaneously breathing, laterally recumbent horses to prolonged anesthesia with halothane. Am J Vet Res 1987; 48:952-957. - PubMed -
79. Hayashi Y, Sumikawa K, Tashiro C, et al. Arrhythmogenic threshold of epinephrine during sevoflurane, enflurane, and isoflurane anesthesia in dogs. Anesthesiol 1988; 69:145-147.
80. Clarke K. Desflurane and sevoflurane: New volatile anesthetic agents. Vet Clin North Am Small Anim Pract 1999; 29:793-810. - PubMed -
81. Doi M, Ikeda K. Respiratory effects of sevoflurane. Anesth Analg 1987; 66:241-244. - PubMed -
82. Aida H, Mizuno Y, Hobo S, et al. Cardiovascular and pulmonary effects of sevoflurane anesthesia in horses. Vet Surg 1996; 25:164-170. - PubMed -
83. Stoelting R. Pharmacology and Physiology in Anesthetic Practice. 3rd ed. Philadelphia: Lippincott-Raven, 1999. - Available from amazon.com -
84. Baden J, Rice S. Metabolim and Toxicity of Inhaled Anesthetics In: RD Miller, ed. Anesthesia. 5th ed. Philadelphia: Churchill Livingston, 2000; 147-173. - Available from amazon.com -
85. Kharasch E, Thummel K. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiol 1993; 79:795-807. - PubMed -
86. Lejus C, Le Roux C, Legendre E, et al. Fluoride excretion in children after sevoflurane anaesthesia. Br J Anaesth 2002; 89:693-696. - PubMed -
87. Holaday D, Smith F. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiol 1981; 54:100-106. - PubMed -
88. Brown B. Sevoflurane, fluoride ion, and renal toxicity-in reply. Anesthesiol 1995; 83:233-234.
89. Malan T, Sameshima T, Mata H. Concentration dependence of sevoflurane metabolism in rats. Am Soc Anesthesiol 1994; A438.
90. Mazze R, Hitt B. Effects of phenobarbital and 3-methylcholanthrene on anesthetic defluorination in Fischer 344 rats. Drug Metab Disp 1978; 6:680-681.
91. Caughey G, Rice S, Kosek J, et al. Effect of phenytoin treatment on methoxyflurane metabolism in rats. J Pharmacol Exp Ther 1979; 210:180-185. - PubMed -
92. Rice S, Talcott R. Effects of isoniazid treatment on selected hepatic mixed-function oxidases. Drug Metab Dispos 1979; 7:260-262. - PubMed -
93. Rice S, Dooley J, Mazze R. Metabolism by rat hepatic microsomes of fluorinated ether anesthetics following ethanol consumption. Anesthesiol 1983; 58:237-241. - PubMed -
94. Schindler E, Hempelmann G. [Perfusion and metabolism of liver and splanchnic nerve territory under sevoflurane]. Der Anaesthesist 1998; 47:S19-23. - PubMed -
95. Kharasch E, Karol M, Lanni C, et al. Clinical sevoflurane metabolism and disposition: I. Sevoflurane and metabolite pharmacokinetics. Anesthesiol 1995; 82:1369-1378. - PubMed -
96. Shichinohe Y, Masuda Y, Takahashi H. A case of postoperative hepatic injury after sevoflurane anesthesia. Masui 1992; 41:1802-1805. - PubMed -
97. Watanabe K, Hatakenaka S, Ikemune K. A case of suspected liver dysfunction induced by sevoflurane anesthesia. Masui 1993; 42:902-905. - PubMed -
98. Nishiyama T, Yokoyama T, Hanaoka K. Effects of sevoflurane and isoflurane anesthesia on arterial ketone body ratio and liver function. Acta Anaesthesiol Scand 1999; 43:347-351. - PubMed -
99. Iwanaga Y, Komatsu H, Yokono S, et al. Serum glutathione S-transferase alpha as a measure of hepatocellular function following prolonged anaesthesia with sevoflurane and halothane in paediatric patients. Paediatr Anaesth 2000; 10:395-398. - PubMed -
100. Steffey EP, Galey F, Mama K, et al. Influence of sevoflurane and desflurane on blood chemical values in horses. Assoc Vet Anaesth 1999; 55-56.
101. Gonsowski C, Laster M, Eger EI 2nd, et al. Toxicity of compound A in rats: effect of increasing duration of administration. Anesthesiol 1994; 80:566-573. - PubMed -
102. Bito H, Ikeda K. Closed-circuit anesthesia with sevoflurane in humans. Anesthesiol 1994; 80:71-76. - PubMed -
103. Bito H, Ikeuchi Y, Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiol 1997; 86:1231-1237. - PubMed -
104. Bito H, Ikeda K. Plasma fluoride and intracircuit degradation product concentrations in long duration, low-flow sevoflurane anesthesia. Anesth Analg 1994; 79:946-951. - PubMed -
105. Goeters C, Reinhardt C, Gronau E, et al. Minimal flow sevoflurane and isoflurane anaesthesia and impact on renal function. Eur J Anaesthesiol 2001; 18:43-50. - PubMed -
106. Eger EI 2nd, Koblin D, Bowland T, et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 84:160-168. - PubMed -
107. Kharasch E, Hankins D, Thummel K. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiol 1995; 82:689-699. - PubMed -
108. Sutcliffe D, Murphy C, Maslow A, et al. A comparison of antagonism of rocuronium-induced neuromuscular blockade during sevoflurane and isoflurane anaesthesia. Anaesthesia 2000; 55:960-964. - PubMed -
109. Kobayashi O, Ohta Y, Kosaka F. Interaction of sevoflurane, isoflurane, enflurane and halothane with non-depolarizing muscle relaxants and their prejunctional effects at the neuromuscular junction. Acta Med Okayama 1990; 44:209-215. - PubMed -
110. Shulman M, Braverman B, Ivankovich A, et al. Sevoflurane triggers malignant hyperthermia in swine (letter). Anesthesiol 1981; 54:259-260.
111. Ochiai R, Toyoda Y, Nishio I, et al. Possible association of malignant hyperthermia with sevoflurane anesthesia. Anesth Analg 1992; 74:616-618.
112. Bruegger D, Bauer A, Finsterer U, et al. Microvascular changes during anesthesia: sevoflurane compared with propofol. Acta Anaesthesiol Scand 2002; 46:481-487. - PubMed -
113. Vitcha J. A History of Forane. Anesthesiol 1971; 35:4-7.
114. Eger EI 2nd. Desflurane - A compendium and reference. Rutherford, NJ: Healthpress Publishing Group, Inc., 1993.
115. Dorsch J, Dorsch S. Understanding Anesthesia Equipment. 4th ed. Baltimore: Lippincott Williams and Wilkins, 1998. - Available from amazon.com -
116. Nathanson M, Fredman B, Smith I, et al. Sevoflurane versus desflurane for outpatient anesthesia: a comparison of maintenance and recovery profiles. Anesth Analg 1995; 81:1186-1190. - PubMed -
117. Mahmoud N, Rose D, Laurence A. Desflurane or sevoflurane for gynaecological day-case anaesthesia with spontaneous respiration? Anaesthesia 2001; 56:171-182. - PubMed -
118. Bennett J, Lingaraju N, Horrow J, et al. Elderly patients recover more rapidly from desflurane than from isoflurane anesthesia. J Clin Anesth 1992; 4:378-381. - PubMed -
119. Eger EI 2nd, Bowland T, Ionescu P, et al. Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-h exposure including kinetics of degradation products. Anesthesiol 1997; 87:517-526. - PubMed -
120. Steffey EP, Woliner MJ. Cardiovascular effects of desflurane in horses (abstr.). Vet Anaesth Analg 2000; 27:106.
121. Tendillo FJ, Mascias A, Santos M, et al. Anesthetic potency of desflurane in the horse: Determination of the minimum alveolar concentration. Vet Surg 1997; 26:354-357. - PubMed -
122. Eger EI 2nd, Strum D. The absorption and degradation of isoflurane and I-653 by dry soda lime at various temperatures. Anesth Analg 1987; 66:1312-1315. - PubMed -
123. Rampil I, Lockhart S, Eger EI 2nd, et al. The electroencephalographic effects of desflurane in humans. Anesthesiol 1991; 74:434-439. - PubMed -
124. Lutz L, Milde J, Milde N. The response of the canine cerebral circulation to hyperventilation during anesthesia with desflurane. Anesthesiol 1991; 74:504-507. - PubMed -
125. Jones N, Clarke K, Clegg P. Desflurane in equine anaesthesia: a preliminary trial. Vet Rec 1995; 137:618-620.
126. Weiskopf R, Cahalan M, Eger EI 2nd, et al. Cardiovascular actions of desflurane in normocarbic volunteers. Anesth Analg 1991; 73:143-156. - PubMed -
127. Warltier D, Pagel P. Cardiovascular and respiratory actions of desflurane: is desflurane different from isoflurane? Anesth Analg 1992; 75:S17-S31. - PubMed -
128. Pagel P, Kampine J, Schmeling W, et al. Comparison of the systemic and coronary hemodynamic actions of desflurane, isoflurane, halothane, and enflurane in the chronically instrumented dog. Anesthesiol 1991; 74:539-551. - PubMed -
129. Clarke K, Song D, Alibhai H, et al. Cardiopulmonary effects of desflurane in ponies, after induction of anaesthesia with xylazine and ketamine. Vet Rec 1996; 139:180-185. - PubMed -
130. Santos M, Tendillo FJ, De Rossi L. Cardiopulmonary effects of desflurane in horses. Sixth Int Con Vet Anaesthesiol 1997; 126.
131. Bettschart-Wolfensberger R, Jaeggin-Schmucker N, Lendl C, et al. Minimal alveolar concentration of desflurane in combination with an infusion of medetomidine for the anaesthesia of ponies. Vet Rec 2001; 148:264-267. - PubMed -
132. Weiskopf R, Eger EI 2nd, Holmes M, et al. Epinephrine-induced premature ventricular contractions and changes in arterial blood pressure and heart rate during I-653, isoflurane, and halothane anesthesia in swine. Anesthesiol 1989; 70:293-298. - PubMed -
133. Klock P, Czeslick E, Klafta J, et al. The Effect of sevoflurane and desflurane on upper airway reactivity. Anesthesiol 2001; 94:963-967. - PubMed -
134. Sutton T, Koblin D, Gruenke L, et al. Fluoride metabolites following prolonged exposure of volunteers and patients to desflurane. Anesth Analg 1991; 73:180-185. - PubMed -
135. Koblin D, Eger EI 2nd, Johnson BH, et al. I-653 resists degradation in rats. Anesth Analg 1988; 67:534-538. - PubMed -
136. Koblin D, Weiskopf R, Holmes M, et al. Metabolism of I-653 and isoflurane in swine. Anesth Analg 1989; 68:147-149. - PubMed -
137. Jones R, Koblin D, Cashman J, et al. Biotransformation and hepato-renal function in volunteers after exposure to desflurane (I-653). Br J Anaesth 1990; 64:482-487. - PubMed -
138. Zaleski L, Abello D, Gold M. Desflurane versus isoflurane in patients with chronic hepatic and renal disease. Anesth Analg 1993; 76:353-356. - PubMed -
139. Hartman J, Pagel P, Proctor L, et al. Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs. Can J Anaesth 1992; 39:877-887. - PubMed -
140. Sundeman H, Aneman A, Broome M, et al. Effects of desflurane on the pig intestinal circulation during hypotension. Acta Anaesthesiol Scand 1999; 43:1069-1077. - PubMed -
141. Schmidt C, Suttner S, Piper S, et al. Comparison of the effects of desflurane and isoflurane anaesthesia on hepatocellular function assessed by alpha glutathione S-transferase. Anaesthesia 1999; 54:1207-1211. - PubMed -
142. Weiskopf RB, Eger EI 2nd, Ionescu P. Desflurane does not produce hepatic or renal injury in human volunteers. Anesth Analg 1992; 74:570-574. - PubMed -
143. Eger EI 2nd, Johnson BH, Strum D, et al. Studies of the toxicity of I-653, halothane and isoflurane in enzyme-induced, hypoxic rats. Anesth Analg 1987; 66:1227-1229. - PubMed -
144. Merin R, Bernerd J-M, Doursout M-F, et al. Comparison of the effects of isoflurane and desflurane on cardiovascular dynamics and regional blood flow in the chronically instrumented dog. Anesthesiol 1991; 74:568-574. - PubMed -
145. Caldwell J, Laster M, Magorian T, et al. The neuromuscular effects of desflurane, alone or combined with pancuronium or succinylcholine in humans. Anesthesiol 1991; 74:412-418. - PubMed -
146. Wedel D, Iaizzo P, Milde J. Desflurane is a trigger of malignant hyperthermia in susceptible swine. Anesthesiol 1991; 74:508-512. - PubMed -
147. Cullen S, Gross E. The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951; 113:580-582.
148. Dingley J, Ivanova-Stoilova T, Grundler S, et al. Xenon: recent developments. Anesthesia 1999; 54:335-346.
149. Froeba G. Xenon als Inhalationanaesthetikum. Anaesthesiologie Intensivmedizin Notfallmedizin Schmerztherapie 1997; 32:48-51.
150. Wenker O. Review of currently used inhalation anesthetics: Part II. The Internet Journal of Anesthesiol 1999; 3.
151. Muir WW, Hubbell JA, Skarda RT, et al. Handbook of Veterinary Anesthesia. 3rd ed. St.Louis: Mosby, 2000. - Available from amazon.com -
152. Grey M, McG Barratt S. Inhalational Anaesthetics: University of Sidney, 2001.
153. Boomsma F, Rupreht J, Man in 't Veld AJ, et al. Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia 1990; 45:273-278. - PubMed -
154. Versichelen L, Bouche M, Rolly G, et al. Only carbon dioxide absorbents free of both NaOH and KOH do not generate compound A during in vitro closed-system sevoflurane: evaluation of five absorbents. Anesthesiol 2001; 95:750-755. - PubMed -
155. Steffey EP, Howland D, Jr., Giri SN, et al. Enflurane, halothane and isoflurane potency in horses. Am J Vet Res 1977; 38:1037-1039. - PubMed -
156. Steffey EP, Howland D, Jr. Potency of halothane-N20 in the horse. Am J Vet Res 1978; 39:1141-6. - PubMed -
157. Eger EI 2nd, Brandstater B, Saidman L, et al. Equipotent alveolar concentrations of methoxyflurane, halothane, diethyl ether, fluroxene, cyclopropane, xenon, and nitrous oxide in the dog. Anesthesiol 1965; 26:771-777.
158. Nakata Y, Goto T, Ishiguro Y, et al. Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans. Anesthesiol 2001; 94:611-614. - PubMed -
159. Drummond J, Matthews R. Nitrous oxide degradation by cobalamin-dependent methionine synthase: Characterization of the reactants and products in the inactivation reaction. Biochemistry 1994; 33:3732-3741. - PubMed -
160. Drummond J, Matthews R. Nitrous oxide inactivation of cobalamin-dependent methionine synthase from Escherichia coli: characterization of the damage to the enzyme and prosthetic group. Biochemistry 1994; 33:3742-3750. - PubMed -
161. Kharasch E, Hankins D, Fenstamaker K, et al. Human halothane metabolism, lipid peroxidation, and cytochromes P450 2A6 and P450 3A4. Eur J Clin Pharmacol 2000; 55:853-859. - PubMed -